{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:51:05Z","timestamp":1781592665576,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010682","name":"H2020 Society","doi-asserted-by":"publisher","award":["825828"],"award-info":[{"award-number":["825828"]}],"id":[{"id":"10.13039\/100010682","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.taap.2025.117520","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:38:54Z","timestamp":1755153534000},"page":"117520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of a complex 3D in vitro alternative model to evaluate the safety of advanced materials"],"prefix":"10.1016","volume":"504","author":[{"given":"Melissa Anne","family":"Tutty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tecla","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117520_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.toxlet.2021.02.009","article-title":"TNF\u03b1 enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy","volume":"342","author":"Ahn","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"16","key":"10.1016\/j.taap.2025.117520_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163327","article-title":"The protective effect of \u03b1-lipoic acid against gold nanoparticles (AuNPs)-mediated liver damage is associated with upregulating Nrf2 and suppressing NF-\u03baB","volume":"14","author":"Alshammari","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.taap.2025.117520_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph15080926","article-title":"Three-dimensional in vitro cell culture models for efficient drug discovery: Progress so far and future prospects","volume":"15","author":"Badr-Eldin","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2025.117520_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115279","article-title":"HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI)","volume":"408","author":"Basharat","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0025","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117520_bb0030","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00204-020-02682-w","article-title":"Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity","volume":"94","author":"Bell","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"17","key":"10.1016\/j.taap.2025.117520_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176225","article-title":"Spheroids as a type of three-dimensional cell cultures-examples of methods of preparation and the Most important application","volume":"21","author":"Bia\u0142kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10456-022-09842-9","article-title":"In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed","volume":"25","author":"Bonanini","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.taap.2025.117520_bb0050","article-title":"Kupffer cell isolation for nanoparticle toxicity testing","volume":"102","author":"Bourgognon","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxres\/tfac087","article-title":"Risk assessment in the 21st century: where are we heading?","volume":"12","author":"Brescia","year":"2023","journal-title":"Toxicol. Res. (Camb)"},{"key":"10.1016\/j.taap.2025.117520_bb0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-2074-7_22","article-title":"Measurement of albumin secretion as functionality test in primary hepatocyte cultures","volume":"1250","author":"Buyl","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202307673","article-title":"The material world of 3D-bioprinted and microfluidic-chip models of human liver fibrosis","volume":"36","author":"Carvalho","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0070","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.taap.2025.117520_bb0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2022.10.028","article-title":"Hepatocyte-specific mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice","volume":"78","author":"Chen","year":"2023","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.taap.2025.117520_bb0080","doi-asserted-by":"crossref","first-page":"035032","DOI":"10.1088\/1758-5090\/ad5766","article-title":"Human iPSC-derived liver co-culture spheroids to model liver fibrosis","volume":"16","author":"Cools","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.taap.2025.117520_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.611913","article-title":"Current perspective: 3D spheroid models utilizing human-based cells for investigating metabolism-dependent drug-induced liver injury","volume":"2","author":"Cox","year":"2020","journal-title":"Front. Med. Technol."},{"issue":"127","key":"10.1016\/j.taap.2025.117520_bb0090","doi-asserted-by":"crossref","first-page":"20160877","DOI":"10.1098\/rsif.2016.0877","article-title":"Advances in multicellular spheroids formation","volume":"14","author":"Cui","year":"2017","journal-title":"J. R. Soc. Interface"},{"issue":"9","key":"10.1016\/j.taap.2025.117520_bb0095","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"de Graaf","year":"2010","journal-title":"Nat. Protoc."},{"issue":"15","key":"10.1016\/j.taap.2025.117520_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158053","article-title":"Critical role of LSEC in post-hepatectomy liver regeneration and failure","volume":"22","author":"De Rudder","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.taap.2025.117520_bb0110","unstructured":"EVOS Cell Imaging Systems."},{"issue":"7","key":"10.1016\/j.taap.2025.117520_bb0115","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1574888X17666220614160957","article-title":"Co-culture of liver parenchymal cells with non-parenchymal cells under 2D and 3D culture systems; a review","volume":"18","author":"Farzaneh","year":"2023","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00204-019-02427-4","article-title":"Integrated in vitro models for hepatic safety and metabolism: evaluation of a human liver-Chip and liver spheroid","volume":"93","author":"Foster","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2025.117520_bb0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3389\/fphar.2019.01667","article-title":"Molecular biomarkers in drug-induced liver injury: challenges and future perspectives","volume":"10","author":"Fu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/C6TX00101G","article-title":"Characterization of a functional C3A liver spheroid model","volume":"5","author":"Gaskell","year":"2016","journal-title":"Toxicol. Res. (Camb)"},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.nano.2013.09.010","article-title":"Non-mammalian vertebrate embryos as models in nanomedicine","volume":"10","author":"Giannaccini","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.taap.2025.117520_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104603","article-title":"Precision-cut tissue slices (PCTS) from the digestive gland of the Mediterranean mussel Mytilus galloprovincialis: an ex vivo approach for molecular and cellular responses in marine invertebrates","volume":"61","author":"Giuliani","year":"2019","journal-title":"Toxicol. in Vitro"},{"issue":"8","key":"10.1016\/j.taap.2025.117520_bb0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.taap.2025.117520_bb0150","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1389557516666160321114341","article-title":"Titanium dioxide nanoparticles: a risk for human health?","volume":"16","author":"Grande","year":"2016","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.taap.2025.117520_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxrep.2017.02.001","article-title":"Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: a pilot study","volume":"4","author":"Granitzny","year":"2017","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41536-022-00266-z","article-title":"Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling","volume":"7","author":"Griffin","year":"2022","journal-title":"NPJ Regen. Med."},{"issue":"22","key":"10.1016\/j.taap.2025.117520_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.taap.2025.117520_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2021.101560","article-title":"Gold nanoparticles: synthesis properties and applications","volume":"33","author":"Hammami","year":"2021","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.taap.2025.117520_bb0175","doi-asserted-by":"crossref","first-page":"574047","DOI":"10.3389\/fmed.2021.574047","article-title":"Liver organoids: recent developments, limitations and potential","volume":"8","author":"Harrison","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"6","key":"10.1016\/j.taap.2025.117520_bb0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s40264-021-01051-5","article-title":"Overview of causality assessment for drug-induced liver injury (DILI) in clinical trials","volume":"44","author":"Hey-Hadavi","year":"2021","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.taap.2025.117520_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.taap.2025.117520_bb0190","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2025.117520_bb0195","series-title":"in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2025.117520_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bcpt.13587","article-title":"3D human liver spheroids for translational pharmacology and toxicology","volume":"130","author":"Ingelman-Sundberg","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfp265","article-title":"The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity","volume":"114","author":"Johnston","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.taap.2025.117520_bb0210","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.taap.2025.117520_bb0215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2025.117520_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/640631","article-title":"Subtoxic concentrations of hepatotoxic drugs Lead to Kupffer cell activation in a human in vitro liver model: an approach to study DILI","volume":"2015","author":"Kegel","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.taap.2025.117520_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12989-014-0056-2","article-title":"Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model","volume":"11","author":"Kermanizadeh","year":"2014","journal-title":"Part. Fibre Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0230","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41598-019-43870-8","article-title":"The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model","volume":"9","author":"Kermanizadeh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117520_bb0235","series-title":"Assay Guidance Manual","article-title":"In vitro 3D spheroids and microtissues: ATP-based cell viability and toxicity assays","author":"Kijanska","year":"2004"},{"issue":"3","key":"10.1016\/j.taap.2025.117520_bb0240","first-page":"192","article-title":"Histopathologic changes associated with fialuridine hepatotoxicity","volume":"10","author":"Kleiner","year":"1997","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.taap.2025.117520_bb0245","first-page":"2004","article-title":"Comparison of different cell culture plates for the enrichment of non-adherent human mononuclear cells","volume":"17","author":"Klinder","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.taap.2025.117520_bb0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.taap.2025.117520_bb0255","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10408444.2012.682115","article-title":"Organotypic liver culture models: meeting current challenges in toxicity testing","volume":"42","author":"LeCluyse","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0260","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1080\/21691401.2019.1687501","article-title":"AuNPs as an important inorganic nanoparticle applied in drug carrier systems","volume":"47","author":"Li","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.taap.2025.117520_bb0265","article-title":"Pharmacotherapies for drug-induced liver injury: a current literature review","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117520_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101652","article-title":"Determination of the nanoparticle- and cell-specific toxicological mechanisms in 3D liver spheroids using scRNAseq analysis","volume":"47","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.taap.2025.117520_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105473","article-title":"Assessing the transferability and reproducibility of 3D in vitro liver models from primary human multi-cellular microtissues to cell-line based HepG2 spheroids","volume":"85","author":"Llewellyn","year":"2022","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2025.117520_bb0280","unstructured":"Luminescent Viability Assays for Magnetically Bioprinted Hepatocyte Spheroids."},{"issue":"7","key":"10.1016\/j.taap.2025.117520_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076248","article-title":"Three-dimensional cell co-culture liver models and their applications in pharmaceutical research","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2025.117520_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052662","article-title":"Engineering hydrogels for the development of three-dimensional in vitro models","volume":"23","author":"Maji","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.taap.2025.117520_bb0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1084952102001301","article-title":"The role of non-parenchymal cells in liver growth","volume":"13","author":"Malik","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2025.117520_bb0300","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/srep02735","article-title":"Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro","volume":"3","author":"Nelson","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117520_bb0305","unstructured":"New Approach Methods Work Plan Available from: https:\/\/www.epa.gov\/system\/files\/documents\/2021-11\/nams-work-plan_11_15_21_508-tagged.pdf."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163929","article-title":"Biliary epithelial cells are facultative liver stem cells during liver regeneration in adult zebrafish","volume":"8","author":"Oderberg","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00204-024-03886-0","article-title":"Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury","volume":"99","author":"Qian","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2025.117520_bb0320","first-page":"1083","article-title":"A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0325","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0022-3549(15)00192-6","article-title":"Co-culture of hepatocytes and Kupffer cells as an in vitro model of inflammation and drug-induced hepatotoxicity","volume":"105","author":"Rose","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0330","doi-asserted-by":"crossref","first-page":"2200169","DOI":"10.1002\/adtp.202200169","article-title":"Comparative study between the 3D-liver spheroid models developed from HepG2 and immortalized hepatocyte-like cells with primary hepatic stellate coculture for drug metabolism analysis and anticancer drug screening","volume":"6","author":"Sae-be","year":"2023","journal-title":"Adv. Therap."},{"issue":"12","key":"10.1016\/j.taap.2025.117520_bb0335","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfq168","article-title":"Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity","volume":"118","author":"Shaw","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2025.117520_bb0345","first-page":"S1","article-title":"Normal liver anatomy","volume":"2","author":"Sibulesky","year":"2013","journal-title":"Clin. Liver. Dis. (Hoboken)"},{"issue":"11\u221212","key":"10.1016\/j.taap.2025.117520_bb0350","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14789450.2021.1876568","article-title":"Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants","volume":"17","author":"Spencer","year":"2020","journal-title":"Expert. Rev. Proteom."},{"key":"10.1016\/j.taap.2025.117520_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.143255","article-title":"Hepatocellular carcinoma (HepG2\/C3A) cell-based 3D model for genotoxicity testing of chemicals","volume":"755","author":"\u0160tampar","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.taap.2025.117520_bb0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-7701-7_13","article-title":"Cell migration in tissues: explant culture and live imaging","volume":"1749","author":"Staneva","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13072-022-00470-7","article-title":"Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model","volume":"15","author":"Stransky","year":"2022","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.taap.2025.117520_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.964553","article-title":"Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health","volume":"4","author":"Stucki","year":"2022","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.taap.2025.117520_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153829","article-title":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","volume":"505","author":"Sun","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2025.117520_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines11010015","article-title":"Treatment of drug-Induced Liver Injury","volume":"11","author":"Teschke","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.taap.2025.117520_bb0385","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1087057113499071","article-title":"A high-throughput\u2013compatible 3D microtissue co-culture system for phenotypic RNAi screening applications","volume":"18","author":"Thoma","year":"2013","journal-title":"SLAS Disc."},{"key":"10.1016\/j.taap.2025.117520_bb0390","series-title":"Three-Dimensional (3D) Hepatic Cell Culture Models to Improve the Clinical Translation of Nanobiomaterials (NBMs)","author":"Tutty","year":"2021"},{"issue":"9","key":"10.1016\/j.taap.2025.117520_bb0395","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s13346-022-01170-1","article-title":"Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity","volume":"12","author":"Tutty","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117520_bb0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/bm990017d","article-title":"Structural and rheological properties of methacrylamide modified gelatin hydrogels","volume":"1","author":"Van Den Bulcke","year":"2000","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0405","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/toxsci\/kfv048","article-title":"Prediction of drug-induced liver injury in micropatterned co-cultures containing iPSC-derived human hepatocytes","volume":"145","author":"Ware","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.taap.2025.117520_bb0410","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.taap.2025.117520_bb0415","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0041-008X(03)00089-9","article-title":"Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers","volume":"189","author":"Xu","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2025.117520_bb0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13770-021-00357-w","article-title":"Liver organoids: formation strategies and biomedical applications","volume":"18","author":"Zhu","year":"2021","journal-title":"Tissue Eng. Regen. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25002960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25002960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:29:06Z","timestamp":1779942546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25002960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":84,"alternative-id":["S0041008X25002960"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117520","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a complex 3D in vitro alternative model to evaluate the safety of advanced materials","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117520"}}